Reviva Pharmaceuticals Holdings, Inc. (RVPH)
0.3676
+0.03
(+8.12%)
USD |
OTCM |
Nov 06, 16:00
Reviva Pharmaceuticals Holdings Net Income (Quarterly) : -2.448M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.448M |
| March 31, 2026 | -3.196M |
| December 31, 2025 | -3.368M |
| September 30, 2025 | -4.011M |
| June 30, 2025 | -6.054M |
| March 31, 2025 | -6.433M |
| December 31, 2024 | -6.260M |
| September 30, 2024 | -8.366M |
| June 30, 2024 | -7.860M |
| March 31, 2024 | -7.434M |
| December 31, 2023 | -9.724M |
| September 30, 2023 | -11.35M |
| June 30, 2023 | -11.71M |
| March 31, 2023 | -6.852M |
| December 31, 2022 | -8.118M |
| Date | Value |
|---|---|
| September 30, 2022 | -3.515M |
| June 30, 2022 | -5.341M |
| March 31, 2022 | -7.365M |
| December 31, 2021 | -3.685M |
| September 30, 2021 | -2.279M |
| June 30, 2021 | -1.608M |
| March 31, 2021 | -0.9493M |
| February 29, 2020 | -0.1317M |
| November 30, 2019 | 0.1368M |
| August 31, 2019 | 0.2743M |
| May 31, 2019 | 0.3384M |
| February 28, 2019 | 0.3066M |
| November 30, 2018 | 0.2632M |
| August 31, 2018 | 0.0177M |
| May 31, 2018 | -0.0133M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 32.72M |
| Corcept Therapeutics, Inc. | 124.49M |
| Veru, Inc. | -6.988M |
| Johnson & Johnson | 210.00M |
| Eli Lilly & Co. | 6.451B |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 2.448M |
| EPS Diluted (Quarterly) | -0.1853 |
| Enterprise Value | -14.93M |
| Earnings Yield | -630.4% |
| Normalized Earnings Yield | -630.41 |